| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |